Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Intra-Cellular Therapies (ITCI) has a market cap of $14.05 billion USD. According to our data, Intra-Cellular Therapies is ranked No.1226 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $14.05 B |
58.30%
|
| Dec 31, 2024 | $8.87 B |
16.62%
|
| Dec 29, 2023 | $7.61 B |
35.34%
|
| Dec 30, 2022 | $5.62 B |
1.11%
|
| Dec 31, 2021 | $5.56 B |
64.59%
|
| Dec 31, 2020 | $3.38 B |
-7.32%
|
| Dec 31, 2019 | $3.65 B |
201.23%
|
| Dec 31, 2018 | $1.21 B |
-21.34%
|
| Dec 29, 2017 | $1.54 B |
-4.04%
|
| Dec 30, 2016 | $1.60 B |
-71.95%
|
| Dec 31, 2015 | $5.71 B |
204.76%
|
| Dec 31, 2014 | $1.88 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
| Market Cap | = | ITCI Stock Price | * | ITCI Shares Outstanding |
| = | $131.87 | * | 0.11 B | |
| = | $14.05 B |